An AI model accurately predicts how cells end up in position inside tissues

Called TopoVelo, the model could lead to better understanding of cellular interactions

5:00 AM

Authors | Elisabeth Paymal | Kelly Malcom

pink stain on microscopic slide
The arrows drawn on top of a microscope image of the tissue (a human embryoid body) show the directions in which the cells are growing.

How do cells come together to make tissues?

To answer this question, the laboratory of Joshua Welch, Ph.D., has developed an A.I. powered computational tool that incorporates space and time into models of cell fate transition.

This modeling, described in a recent issue of Nature Biotechnology, constitutes a key step toward characterizing how interactions and environment among neighboring cells and cell migration contribute to tissue development.

“Previous studies have modeled cell differentiation like a physical process in which a cell is a point mass moving through space with some velocity. But cells exert forces on each other much like bodies in space interact through gravity and momentum transfer,” explained Welch, an associate professor of computational medicine and bioinformatics at the Medical School, and principal investigator for the study.

“Inspired by this analogy, we used artificial intelligence to model how the gene expression levels of cells from an entire tissue influence each other while the cells differentiate.”

Called Topological Velocity Inference (TopoVelo), the Welch model jointly infers how cells change in location over time from data detailing where genes are expressed in tissue.

“Previous research has measured the direction and speed that cells are moving, but cells are not moving alone: they are all bumping into each other and pulling on each other, much like gravity pulls planets together,” he explained.

The Welch lab used TopoVelo, a type of graph neural network, to estimate cell velocity from the developing mouse cerebral cortex and found that it learns the location and maturity of cells based on the expression of ligand-receptor genes–genes that facilitate the connection of one molecule to another–revealing spatial signatures of mouse neural tube closure, a critical point of early development.

Extending the model to humans, the Welch lab generated Slide-seq data, which reveals where genes are expressed in a tissue, from an in vitro model of human development and used TopoVelo to study the spatial patterns of early differentiation.

“There are many diseases, such as neuronal migration disorders, that evolve from incorrect cell migration and models like this provide a way to determine what’s causing migration defects and how we could potentially correct them,” Welch said.

The A.I. model could also provide a better understanding of the cell-cell interactions underlying inflammatory responses.

Additionally, said Welch, TopoVelo could provide the insight to engineer better organoids by more correctly modeling how cells under investigation differentiate.

Additional authors: Yichen Gu, Jialin Liu, Kun H. Lee, Chen Li, Lu Lu, Jaimee Moline, Renxiang Guan

Funding/disclosures: National Institutes of Health grants R01 HG010883 and UM1 MH130966

Paper cited: “Topological velocity inference from spatial transcriptomic data,” Nature Biotechnology . DOI: 10.1038/s41587-025-02688-8


More Articles About:

Future Think Artificial intelligence (AI) All Research Topics
Health Lab word mark overlaying blue cells

Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

In This Story

Joshua Welch

Joshua Welch, PhD

Associate Professor

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

lights scattered all over blue screen connected
Health Lab

Studying neurons using neurons

Labs at the University of Michigan Medical School are exploring a new technology that leverages the biological capabilities of human neurons for artificial intelligence.
real hand touching robot hand connecting in middle
Health Lab

The algorithm will see you now? Patients say not without a doctor nearby

Researchers at the University of Michigan and Michigan State University found that U.S. adults were significantly more likely to trust in and choose medical AI in scenarios with better AI performance, U.S. Food and Drug Administration approval, national and local certifications, the presence of a clinician, and the use of representative data.
woman looking at screen in office clinical area
Health Lab

How AI is helping emergency physicians learn from their patients

How the “Tell Me What Happens Next” initiative is being used by the Department of Emergency Medicine’s new Division of Clinical Informatics using artificial intelligence.
baby with hearing aid on ear looking from side view with blue pacifier in mouth
Health Lab

Research may help better predict outcomes in kids with congenital cytomegalovirus

Two new studies may help researchers and clinicians better understand congenital cytomegalovirus (CMV), the most common infectious cause of birth defects and a leading cause of non-genetic hearing loss in children.
couple walking by the water
Health Lab

Michigan’s aging brains need more protection, poll shows

Lifestyle changes can reduce risk of Alzheimer’s disease and other forms of dementia but a poll shows many Michiganders over 50 don’t know about or do them.
A team of medical professionals in surgical attire performs a procedure in an operating room. They are surrounded by medical equipment, including a robotic arm and various monitors.
News Release

University of Michigan implants first-in-human Paradromics wireless brain-computer interface, designed to restore communication

Neurosurgeons at University of Michigan Health completed the first-in-human implantation of a Paradromics Inc., wireless brain-computer interface, or BCI, as part of a national clinical trial for patients with difficulty speaking.